Published in Cancer Weekly, February 20th, 1995
Bertelsen et al. note that with the onset of molecular biology, the influx of information forthcoming about the molecular aspects of neoplasia provides oncologists with better targets against which to design more specific and effective drugs against cancer.
The discovery of oncogenes and tumor suppressor genes provide potential targets for cancer treatments. Currently, there are no available treatments to address the loss of a tumor suppressor gene. Such therapeutic approaches could...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.